Accurate, absolute, actionable lung fluid measurement for heart failure patients

What is ReDS™?

ReDS™ is an easy-to-use, noninvasive system for the monitoring and management of lung fluid in patients with Heart Failure and other fluid management problems.

5.7M

HF Patients in the US

$30.7B

Yearly Cost of Heart Failure

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.Terms and ConditionsPrivacy PolicyNotice of Privacy PracticesNotice of NondiscriminationManage Cookies""To evaluate the role of inhaled ipratropium bromide in acute asthma, a double-blind study of 384 emergency department patients compared the effect of the combination of ipratropium and albuterol with that of albuterol alone. Order Atrovent 1 bottle (Aproven) Canadian Online Pharmacy Albuterol and ipratropium combination is used by people whose symptoms have not been controlled by a single inhaled medication. However, because imprecision around the findings in the modified intention-to-treat analysis included a clinically important difference favoring cephalexin plus trimethoprim-sulfamethoxazole, further research may be needed. Where to buy Cephalexin 750mg (Keflex) no Prescription If your dog has diabetes, you should use the capsule form, as the liquid form may contain sugar.

87%

Potential Reduction in Hospital
Readmissions

45

45-Second Measurements
Help Physicians Assess the Status
of the Patient’s Heart Failure

Payers

A cost-effective, end-to-end service that can reduce patient medical expenses

PROVIDERS

Noninvasive lung fluid measurement for informed decision-making, and improved care for Heart Failure patients

PATIENTS

Like your favorite blanket, the ReDS™ system wraps you in the best technology to help your doctor manage your Heart Failure and keep you safe at home.

“What we’ve needed for a long time is a more accurate and actionable measurement of heart failure clinical status. We get that with ReDS™.”

Dr. William Abraham, MD Director, Division of Cardiovascular Medicine, Professor of Internal Medicine at Ohio State University

“We were looking for a technology that would be noninvasive, yet offer accuracy. This search led us to ReDS™.”

Daniel BenSimhon, MD Medical Director, Advanced Heart Failure & Mechanical Circulatory Support Program – ConeHealth

RECENTLY IN THE MEDIA:

07.23.22

Terumo India Signs a New Strat ...

Terumo India , the Indian arm of Terumo Corporation (TSE: 4543), a global leader...

Read more

04.16.20

Sensible Medical ReDS Lung Flu ...

Hospitals treating COVID-19 patients are looking to use the radar-based technolo...

Read more

UPCOMING EVENTS